Merck (MRK) Interest Expenses (2011 - 2013)

Merck has disclosed Interest Expenses across 3 years of filings, most recently posting $184.0 million for Q1 2013.

• In Q1 2013, Interest Expenses rose 5.14% year-over-year to $184.0 million; the TTM figure through Dec 2013 stood at $184.0 million (down 74.27% YoY), while the FY2012 annual figure was $714.0 million, up 2.73% from the prior year.
• Interest Expenses retreated to $184.0 million in Q1 2013, from $190.0 million in the prior quarter.
• Over the last five years, Interest Expenses for MRK reached as high as $190.0 million in Q4 2012 and fell as low as $170.0 million in Q2 2011.
• The 3-year median for Interest Expenses is $176.0 million (2011), against an average of $178.2 million.
• The widest YoY moves for Interest Expenses: up 9.83% in 2012, down 5.91% in 2012.
• A 3-year view of Interest Expenses shows it stood at $173.0 million in 2011, then climbed by 9.83% to $190.0 million in 2012, then dropped by 3.16% to $184.0 million in 2013.
• According to Business Quant data, Interest Expenses over the past three periods registered $184.0 million, $190.0 million, and $178.0 million for Q1 2013, Q4 2012, and Q3 2012 respectively.